Question and answers - Addressing cardiovascular risk in type 2 diabetes - The LEADER trial.
28 August 2016 (19:25 - 20:00)
Organised by:
About the speaker
Karolinska Institute, Stockholm (Sweden)
4 More presentations in this session
Professor L. Ryden (Stockholm, SE)
Professor S. Nissen (Cleveland, US)
Access the full session
The Event
ESC Congress 2016
28 August 2016
19:25 CET
